Dashboard
Manage Tickers

IMNN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 21:07:03

imunon-to-present-phase-3-ovation-3-clinical-trial-imnn-001-at-esmo-congress
IMUNON To Present Phase 3 OVATION 3 Clinic...
10/14/2025 12:21:05

Prestigious European Society for Medical Oncology Conference "trials-in-progress" sessionPivotal OVATION 3 trial of its...

imunon-presents-imnn-001-phase-2-translational-data-in-ovarian-cancer-results-showed-13-month-increase-in-overall-survival
IMUNON Presents IMNN-001 Phase 2 Translati...
09/22/2025 12:06:58

imunon-to-present-new-translational-data-from-phase-2-ovation-2-study-of-imnn-001-at-2025-aacr-special-conference-in-cancer-research
IMUNON To Present New Translational Data F...
09/19/2025 12:07:43

OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treatedLAWRENCEVILLE, N.J., Sept. ...

imunon-regains-nasdaq-compliance
IMUNON Regains Nasdaq Compliance
08/28/2025 12:08:30

imunon-q2-2025-eps-215-may-not-be-comparable-to-034-estimate-cash-and-cash-equivalents-were-47m-expected-to-provide-cash-runway-into-q4-2025
Imunon Q2 2025 EPS $(2.15) May Not Be Comp...
08/05/2025 12:04:47

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

insights-into-imunons-upcoming-earnings
Insights into Imunon's Upcoming Earnings
08/04/2025 21:03:29

imunon-imnn-stock-is-trending-wednesday-whats-going-on
IMUNON (IMNN) Stock Is Trending Wednesday:...
07/30/2025 15:48:30

Shares of IMUNON are trading higher Wednesday morning. The company announced a clinical milestone for its lead drug candidate, ...

imunon-doses-first-patient-in-phase-3-ovation-3-study-of-imnn-001-for-ovarian-cancer
IMUNON Doses First Patient In Phase 3 OVAT...
07/30/2025 12:07:53

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/24/2025 23:50:05

imunon-announces-1-for-15-reverse-stock-split-effective-july-25-2025
IMUNON Announces 1-For-15 Reverse Stock Sp...
07/23/2025 12:09:46

IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 12:08:15

imunon-files-prospectus-to-register-additional-45m-in-common-stock-for-at-the-market-offering-increasing-total-to-10m
Imunon Files Prospectus To Register Additi...
07/22/2025 12:10:11

- SEC Filing

imunon-receives-nasdaq-panel-approval-to-execute-compliance-plan
IMUNON Receives Nasdaq Panel Approval To E...
07/15/2025 12:14:16

imunon-submits-plan-to-nasdaq-to-regain-compliance-with-minimum-bid-price-requirement
IMUNON Submits Plan To Nasdaq To Regain Co...
06/30/2025 12:11:31

imunon-highlights-presentation-of-translational-data-from-phase-2-ovation-2-study-of-imnn-001
IMUNON Highlights Presentation Of Translat...
06/18/2025 12:07:57

imunon-showcases-placcine-vaccines-six-month-durability-stability-and-manufacturing-edge-over-mrna-seeks-strategic-partner-for-advancement
IMUNON Showcases PlaCCine Vaccine's Six-Mo...
06/17/2025 12:07:09

Clinical Data Highlight PlaCCine's Six-Month Durability, Temperature Stability, and Manufacturing Advantages Over mRNA Vacc...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
06/16/2025 17:06:02

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
06/16/2025 12:08:38

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION